---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-177539"
form_type: "8-K"
ticker: "FNCHQ"
cik: "0001733257"
company_name: "Finch Therapeutics Group, Inc."
filed_at: "2023-06-28T23:59:59+00:00"
generated_at: "2026-06-13T15:36:37.753810+00:00"
event_type: "regulatory"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Finch Therapeutics regains compliance with Nasdaq minimum bid price requirement

## Summary
- Received letter from Nasdaq on June 27, 2023 confirming regained compliance with Listing Rule 5450(a)(1).
- Closing bid price was $1.00 or greater for 10 consecutive business days from June 12 to June 26, 2023.
- Previously notified of deficiency on Dec 30, 2022; compliance deadline was June 28, 2023.
- Nasdaq considers the compliance matter closed; no further action required.

## SEC filing metadata
- accession: 0001193125-23-177539
- form_type: 8-K
- ticker: FNCHQ
- cik: 0001733257
- company_name: Finch Therapeutics Group, Inc.
- filed_at: 2023-06-28T23:59:59+00:00
- event_type: regulatory
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1733257/000119312523177539/0001193125-23-177539-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1733257/000119312523177539/d510150d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-177539
- JSON: https://secwatch.observer/filing/0001193125-23-177539.json
- Plain text: https://secwatch.observer/filing/0001193125-23-177539.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.